Depth of Invasion Threshold for Recommending Elective Neck Dissection in T1 or T2 Oral Squamous Cell Carcinoma

被引:0
|
作者
Shih, Hans [1 ,2 ]
Khanna, Mehak [2 ]
Thomas, Jacob [1 ]
Makhoul, Nicholas Maroun [1 ]
El-Hakim, Michel [2 ]
机构
[1] McGill Univ, Dept Oral & Maxillofacial Surg, Hlth Ctr, Montreal, PQ, Canada
[2] McGill Univ, Fac Dent Med & Oral Hlth Sci, Montreal, PQ, Canada
关键词
CAVITY; MANAGEMENT; DECISION; DISEASE; RISK;
D O I
10.1016/j.joms.2024.10.006
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: There is variability in the literature on the role of the depth of invasion (DOI) for recommending an elective neck dissection (END). Purpose: The purpose of the study is to estimate the DOI threshold for recommending an END. Study Design, Setting, Sample: A retrospective cohort study was performed at McGill University Health Centre from 2008 to 2018 with 5 years of follow-up. The sample was subjects with clinical T1/T2 oral squamous cell carcinoma and clinically negative neck. Subjects with previous head and neck cancer were excluded. Predictor Variable: The primary predictor variable was DOI measured from the basement membrane of the adjacent normal mucosa on final pathology, coded as <4 mm or >= 4 mm. DOI is a continuous variable converted to a binary variable. Main Outcome Variable: The main outcome variable was time to development of neck disease (RD+) defined as the time from surgery to development of pathologic nodes. Time to RD+ for pathologic nodes discovered from the END was considered 0 months. The secondary outcome variable was overall survival. Covariates: Demographics (age, sex, and smoking/alcohol history) and tumor characteristics (tumor location, clinical T, tumor differentiation, perineural invasion, and lymphovascular invasion) were analyzed. Analyses: Time to RD+ and survival were analyzed using Cox hazard ratio, Kaplan-Meier curves, and log-rank test. Student's t-test and chi(2) test were used for bivariate analyses; P <= .05 was statistically significant. Results: The final sample were 64 subjects (average age 65.25 [standard deviation 13.06] years and 36 [56.2%] males). Twenty-nine subjects had DOI < 4 mm, and the 5-year RD+ was 3.4% (the 1 occurrence of RD+ was at 5.3 months). Thirty-five subjects had DOI >= 4 mm, and the 5-year RD+ was 45.7% (15 subjects had RD+ discovered from the END, and 1 subject had RD+ at 7.6 months). DOI >= 4 mm had significantly higher risk of RD+ than DOI < 4 mm (hazard ratio 17.91; 95% confidence interval 2.37 to 135.3; P = .01), which remained significant after adjusting for clinical T, tumor differentiation, perineural invasion, and lymphovascular invasion (hazard ratio 9.53; 95% confidence interval 1.12 to 81.44; P < .05). The shallowest DOI with >20% risk of RD+ was in the DOI 4 mm to 4.9 mm group. Conclusion and Relevance: Among patients with oral squamous cell carcinoma of T1 or T2 and clinically negative necks, END should be considered with DOI >= 4 mm. (c) 2025 The Authors. Published by Elsevier Inc. on behalf of the American Association of Oral and Maxillofacial Surgeons. This is an open access article under the CC BY-NC license (http:// creativecommons.org/licenses/by-nc/4.0/).
引用
收藏
页码:102 / 112
页数:11
相关论文
共 50 条
  • [21] Clinical Results of T1 and T2 Squamous Cell Carcinoma of the Esophagus
    Hisanaga, T.
    Kinugasa, S.
    Tachibana, M.
    Ueda, S.
    Yamamoto, R.
    Hyakudomi, R.
    Shimojo, Y.
    Hirahara, N.
    Tanaka, T.
    PROCEEDINGS OF THE 11TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY FOR DISEASES OF THE ESOPHAGUS, 2008, : 163 - 165
  • [22] T1 and T2 mapping for identifying malignant lymph nodes in head and neck squamous cell carcinoma
    Qu, Jiangming
    Pan, Boju
    Su, Tong
    Chen, Yu
    Zhang, Tao
    Chen, Xingming
    Zhu, Xiaoli
    Xu, Zhentan
    Wang, Tianjiao
    Zhu, Jinxia
    Zhang, Zhuhua
    Feng, Feng
    Jin, Zhengyu
    CANCER IMAGING, 2023, 23 (01)
  • [23] T1 and T2 mapping for identifying malignant lymph nodes in head and neck squamous cell carcinoma
    Jiangming Qu
    Boju Pan
    Tong Su
    Yu Chen
    Tao Zhang
    Xingming Chen
    Xiaoli Zhu
    Zhentan Xu
    Tianjiao Wang
    Jinxia Zhu
    Zhuhua Zhang
    Feng Feng
    Zhengyu Jin
    Cancer Imaging, 23
  • [24] Efficacy of Elective Neck Dissection in T1/T2N0M0 Oral Tongue Squamous Cell Carcinoma: A Population-Based Analysis
    Patel, Tapan D.
    Vazquez, Alejandro
    Marchiano, Emily
    Sanghvi, Saurin
    Eloy, Jean Anderson
    Baredes, Soly
    Park, Richard Chan Woo
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2016, 155 (04) : 588 - 597
  • [25] Isolated Skip Nodal Metastasis Is Rare in T1 and T2 Oral Tongue Squamous Cell Carcinoma
    Balasubramanian, Deepak
    Thankappan, Krishnakumar
    Battoo, Azhar Jan
    Rajapurkar, Mayuri
    Kuriakose, Moni Abraham
    Iyer, Subramania
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2012, 147 (02) : 275 - 277
  • [26] Photodynamic Therapy Outcome for T1/T2 N0 Oral Squamous Cell Carcinoma
    Jerjes, Waseem
    Upile, Tahwinder
    Hamdoon, Zaid
    Mosse, Charles Alexander
    Morcos, Mira
    Hopper, Colin
    LASERS IN SURGERY AND MEDICINE, 2011, 43 (06) : 463 - 469
  • [27] DEFINITIVE RADIOTHERAPY FOR T1 AND T2 SQUAMOUS-CELL CARCINOMA OF THE TONSIL
    MOOSE, BD
    KELLY, MD
    LEVINE, PA
    CONSTABLE, WC
    CANTRELL, RW
    LARNER, JM
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1995, 17 (04): : 334 - 338
  • [28] Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus
    Tachibana, M
    Kinugasa, S
    Dhar, DK
    Tabara, H
    Masunaga, R
    Kotoh, T
    Kubota, H
    Nagasue, N
    ARCHIVES OF SURGERY, 1999, 134 (01) : 50 - 54
  • [29] Neck observation versus elective neck dissection in management of clinical T1/2N0 oral squamous cell carcinoma: a retrospective study of 232 patients
    Liu, Xiangqi
    Lao, Xiaomei
    Liang, Lizhong
    Zhang, Sien
    Li, Kan
    Liao, Guiqing
    Liang, Yujie
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (03) : 179 - 188
  • [30] MANAGEMENT OF T1 AND T2 SQUAMOUS-CELL CARCINOMA OF THE GLOTTIC LARYNX
    MENDENHALL, WM
    PARSONS, JT
    MILLION, RR
    MAYO CLINIC PROCEEDINGS, 1992, 67 (07) : 703 - 705